Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial)

Previous studies among patients with atrial fibrillation showed that a history of heart failure (HF) could negatively impact anticoagulation quality, as measured by the average time in therapeutic range (TTR). Whether additional markers of HF severity are associated with TTR has not been investigate...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Cardiol
Hlavní autoři: Lee, Tetz C., Qian, Min, Lip, Gregory Y.H., Di Tullio, Marco R., Graham, Susan, Mann, Douglas L., Nakanishi, Koki, Teerlink, John R., Freudenberger, Ronald S., Sacco, Ralph L., Mohr, J.P., Labovitz, Arthur J., Ponikowski, Piotr, Lok, Dirk J., Estol, Conrado, Anker, Stefan D., Pullicino, Patrick M, Buchsbaum, Richard, Levin, Bruce, Thompson, John L.P., Homma, Shunichi, Ye, Siqin
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6151139/
https://ncbi.nlm.nih.gov/pubmed/30037426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2018.05.024
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky